Zobrazeno 1 - 10
of 25 156
pro vyhledávání: '"11"'
Autor:
Théodora Mahoukèdè Zohoncon, Herman Karim Sombie, Pegdwendé Abel Sorgho, Isabelle Touwendpoulimdé Kiendrebeogo, Sidnooma Véronique Zongo, Bapio Valery Jean Télesphore Elvira Bazie, Jacques Simpore, Nayi Zongo, Florencia W. Dijgma, Albert Théophane Yonli, Lassina Traore, Lanyo Jospin Amegnona, Doriane Tatiana Lallogo, Marie N. L. Ouedraogo, Fabienne Ingrid Zongo, Aboubacar Hierrhum Bambara, Alexis Yobi Sawadogo, Abdou Azaque Zoure
Publikováno v:
Open Life Sciences, Vol 16, Iss 1, Pp 1101-1110 (2021)
Open Life Sciences
Open Life Sciences
Several factors contribute to the development of breast cancer, including the immune system. This study is aimed to characterize the carriage of human leukocyte antigen (HLA)-DRB1*11 and 1*12 alleles in patients with breast cancer. This case-control
Publikováno v:
OncoTargets and therapy
Hongzhu Zhang,1,* Tingting Fu,1,* Cuiping Zhang2 1Department of Gastroenterology, Jinan Jigang Hospital, Jinan, Shandong, 250101, People’s Republic of China; 2Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, S
Autor:
Lv, Ang1, Li, Zhongwu2, Tian, Xiuyun1, Guan, Xiaoya1, Zhao, Min3, Dong, Bin3, Hao, Chunyi1 haochunyi@126.com
Publikováno v:
PLoS ONE. May2013, Vol. 8 Issue 5, p1-11. 11p.
Autor:
Bingnan Zhang, Kavya Ramkumar, Robert John Cardnell, Carl Michael Gay, C. Allison Stewart, Wei-Lien Wang, Junya Fujimoto, Ignacio I. Wistuba, Lauren Averett Byers
Publikováno v:
Br J Cancer
DNA-damaging agents exploit increased genomic instability, a hallmark of cancer. Recently, inhibitors targeting the DNA damage response (DDR) pathways, such as PARP inhibitors, have also shown promising therapeutic potential. However, not all tumors
Publikováno v:
European Journal of Cancer. 148:230-238
Background Complete remission is observed in less than half of hypermutated (HM) tumours after immune checkpoint blockade therapy, indicating that HM tumours are very heterogeneous. Thus, there is an urgent requirement to decipher the unknown intrins
Autor:
Moisés M. da Rocha, Mariana Tavares de Souza, Moneeb A.K. Othman, Marcelo Gerardin Poirot Land, Elaine Sobral da Costa, Kelly C D A Monteso, Roberto R. Capela de Matos, Daniela R. Ney Garcia, Maria Luiza Macedo Silva, Luiza F Albagli, Thomas Liehr
Publikováno v:
Journal of pediatric hematology/oncology. 43(3)
KMT2A gene rearrangements represent the most frequent group of abnormalities in childhood leukemia (~70% of cases), with over 120 rearrangements described. The investigation of KMT2A rearrangements is still a vast field to be explored. Several studie
Autor:
Weiguo Jin, Ling-Feng Min, Chao Sun, Yiwei Fan, Xiaolin Wang, Hongcan Shi, Shichun Lu, Yusheng Shu
Publikováno v:
Cancer Biol Ther
Evidence suggests that Tripartite Motif Containing 11 (TRIM11) has pro-tumor activity in human non-small cell lung cancer (NSCLC). However, the roles and underlying mechanisms of TRIM11 in NSCLC have not yet been fully elucidated. In this work, human
Autor:
AS Borovkova, NN Mamaev, TL Gindina, Elena I. Darskaya, Sergey N. Bondarenko, YaV Gudozhnikova, L.S. Zubarovskaya, OA Slesarchuk, BV Afanas’ev, O.V. Paina, P.V. Kozhokar, AL Alyanskii
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 342-350 (2017)
Aim. The aim was to evaluate the results of the allogeneic hematopoietic stem cells transplantation (allo-HSCT) in children and adults with the most prognostically unfavorable acute lymphoblastic leukemia (ALL) with t(4; 11)(q21; q23)/KMT2A-AFF1 tran
Autor:
Joanna Weinstein, Rachel A. Mariani, Kai Lee Yap, Shunyou Gong, Edward Caparelli, Lawrence J. Jennings, Katrin M. Leuer, Mercedes Silva
Publikováno v:
Journal of pediatric hematology/oncology. 42(4)
T-cell therapy-related acute lymphoblastic leukemia (T-t-ALL) is a rare condition associated with previous cytotoxic therapy for another disease. Here we report T-t-ALL with inv(11)(q21q23), which involves KMT2A and MAML2, a transcriptional coactivat
Autor:
Ryosuke Matsushita, Masayuki Nakagawa, Hirofumi Yoshino, Hideki Enokida, Masaya Yonemori, Kazutaka Miyamoto, Naohiko Seki
Publikováno v:
Cancer Science
Our recent study of the microRNA (miRNA) expression signature of bladder cancer (BC) by deep-sequencing revealed that two miRNA, microRNA-139-5p/microRNA-139-3p were significantly downregulated in BC tissues. The aim of this study was to investigate